Dr Reddy’s shares in focus after $50 million acquisition for entry in anti-vertigo category |ArticlePulseHub

The Times of India

Chance
September 12, 2025
0 Comments

Shares of Dr Reddy’s Laboratories will be in focus on Thursday, September 11, after the company announced it has signed a definitive pact with Janssen Pharmaceutica NV, a Johnson & Johnson unit, …

Our Recent Article

Dr Reddy’s shares in focus after $50 million acquisition for entry in anti-vertigo category

@chancenyasulu

0 comments

Your comment

Recent Posts

Kenny Chesney shares painful truth behind his unexpected on-stage tears during Indianapolis concert

Fan waving American flag storms field in Game 6 of World Series, sparking boos from Canadian crowd

Shohei Ohtani faces unique MLB rule challenge in winner-take-all Game 7 World Series showdown

Categories

Tag Clouds